Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Alphabet, ServiceNow, Salesforce, Intuitive Surgical, and UnitedHealth Group are the five Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares ...
16d
Daily Freeman on MSNAfter Ryan’s call for probe, Optum says it has made improvements at medical facilitiesA healthcare company targeted by U.S. Rep. Pat Ryan as part of a service probe said that its facilities have undergone much in the way of improvement since it acquired them. In a ...
Aetna Inc. and OptumHealth Care Solutions Inc. signed a settlement worth $8.35 million that’s aimed at resolving a class ...
In a statement, Optum said that the efforts have been made on a variety of fronts to improve services for patients. “Since these practices chose to join Optum, we have introduced a number of new ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies, UnitedHealth Group, has added a new, much-anticipated pain drug to some of its commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results